Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach.

Histopathology
Karen L TaliaW Glenn McCluggage

Abstract

The morphological spectrum of primary ovarian mucinous and seromucinous tumours is broad, and presents an array of diagnostic challenges, many unique to these tumour types. This reflects the heterogeneous nature of these lesions, their varied histogenesis and evolving classification systems over recent decades, with further modification to the seromucinous category incorporated in the recently published 5th edition of the World Health Organisation (WHO) Classification of female genital tumours. In this review we provide an update on the classification of these neoplasms and discuss their histogenesis and diverse morphology, focusing on areas which are diagnostically problematic. We also cover tumour grading, differential diagnosis, immunohistochemistry, the recent elucidation of the molecular underpinnings of ovarian mucinous neoplasia and discuss the gross and intra-operative handling of these tumours. A number of diagnostic issues remain unresolved, highlighting the importance of further research on this front, as well as a multidisciplinary approach in the care of patients with ovarian mucinous and seromucinous neoplasia.

References

Aug 1, 1990·Gynecologic Oncology·T GramlichM Lutz
Jan 1, 1990·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·B Lifschitz-MercerB Czernobilsky
Jan 1, 1994·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·R N Baergen, J L Rutgers
Jun 1, 1996·Human Pathology·R NayarS G Silverberg
Jan 1, 1997·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·B M RonnettR J Kurman
Oct 8, 1998·British Journal of Obstetrics and Gynaecology·P VercelliniP G Crosignani
Dec 16, 1998·The American Journal of Surgical Pathology·H D Hoerl, W R Hart
Jan 29, 2002·The American Journal of Surgical Pathology·Ingrid M Rodríguez, Jaime Prat
Feb 27, 2003·The American Journal of Surgical Pathology·Kenneth R Lee, Robert H Young
Mar 22, 2003·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Mikio MikamiTakanori Hirose
Apr 30, 2003·The American Journal of Surgical Pathology·Brigitte M Ronnett, Jeffrey D Seidman
Dec 12, 2003·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Jeffrey D SeidmanBrigitte M Ronnett
Aug 7, 2004·Human Pathology·Steven G SilverbergRobert H Young
Sep 17, 2004·The American Journal of Surgical Pathology·Ingrid M RodriguezJaime Prat
Mar 23, 2005·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Valérie DubéBernard Têtu
May 14, 2005·Human Pathology·Tzu-Yu HuangWilliam L Ho
Jun 22, 2005·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Catherine LudwickPhilip B Clement
Nov 19, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Russell VangBrigitte M Ronnett
Nov 25, 2005·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Russell VangBrigitte M Ronnett
Oct 26, 2006·The American Journal of Surgical Pathology·Elvio G SilvaMichael Deavers
Aug 21, 2007·Journal of Clinical Pathology·W G McCluggage
Mar 18, 2008·The American Journal of Surgical Pathology·Jesse K McKenneyTeri A Longacre
Mar 21, 2008·Fertility and Sterility·Ioannis M MatalliotakisAnastasia G Goumenou
Jul 8, 2008·Human Pathology·C Blake GilksUNKNOWN Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency
Aug 2, 2008·The American Journal of Surgical Pathology·W Glenn McCluggage, Robert H Young
Feb 23, 2010·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Andres G ChiesaAnais Malpica
Apr 22, 2010·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Tung-Ying ChenTao-Yeuan Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.